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Mechanistic Studies of the Long Chain Acyl-CoA Synthetase
Faa1p from Saccharomyces cerevisiae
Hong Li1,2, Elaina M. Melton1,2, Steven Quackenbush1,2, Concetta C. DiRusso1,2, and Paul
N. Black1,2
1Center for Metabolic Disease, Ordway Research Institute, Albany New York 12208
2Center for Cardiovascular Sciences, Albany Medical College, Albany, New York 12208

Abstract
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Long chain acyl-CoA synthetase (ACSL; fatty acid CoA ligase: AMP forming; EC 6.2.1.3) catalyzes
the formation of acyl-CoA through a process, which requires fatty acid, ATP and coenzymeA as
substrates. In the yeast Saccharomyces cerevisiae the principal ACSL is Faa1p (encoded by the
FAA1 gene). The preferred substrates for this enzyme are cis-monounsaturated long chain fatty acids.
Our previous work has shown Faa1p is a principal component of a fatty acid transport/activation
complex that also includes the fatty acid transport protein Fat1p. In the present work hexameric
histidine tagged Faa1p was purified to homogeneity through a two-step process in the presence of
0.1% η-dodecyl-β-maltoside following expression at 15°C in Escherichia coli. In order to further
define the role of this enzyme in fatty acid transport-coupled activation (vectorial acylation), initial
velocity kinetic studies were completed to define the kinetic parameters of Faa1p in response to the
different substrates and to define mechanism. These studies showed Faa1p had a Vmax of 158.2 nmol/
min/mg protein and a Km of 71.1µM oleate. When the concentration of oleate was held constant at
50µM, the Km for CoA and ATP were 18.3µM and 51.6µM respectively. These initial velocity studies
demonstrated the enzyme mechanism for Faa1p was Bi Uni Uni Bi Ping Pong.
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INTRODUCTION
Long chain acyl-CoA synthetase (ACSL; fatty acid CoA ligase: AMP forming; EC 6.2.1.3)
occupies a central position in the metabolism of fatty acids through oxidative and non-oxidative
pathways including the synthesis of complex membrane lipids and the synthesis and
mobilization of storage lipids including triglycerides and sterol esters. It has become
increasingly apparent that separate ACSL isoforms provide unique roles in these pathways
including the transport of exogenous fatty acids into the cell [1], the targeting of fatty acids
into specific metabolic pathways [2], and in fatty acid-mediated transcriptional control [3,4].
Under-expression of certain ACSL isoforms can compromise the ability of a cell to store or
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oxidize fatty acids leading to decreased cellular function. Overexpression, on the other hand,
can lead to excess accumulation of toxic lipids and cell death [5].
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In the yeast Saccharomyces cerevisiae, four long chain ACSL isoforms with unique expression
profiles, cellular localizations and functions have been described [6,7]. In addition, yeast cells
also have short chain and very long-chain acyl-CoA synthetases [8–10]. The very long chain
acyl-CoA synthetase has also been described as a fatty acid transport protein, which functions
in concert with ACSL in the transport-coupled activation of exogenous fatty acids (vectorial
acylation) [8,11]. Faa1p is the major ACSL in yeast accounting for nearly 90% of the long
chain activity [3,7,12]. While a second ACSL, Faa4p, can partially compensate for lack of
Faa1p activity, many cellular functions are compromised in cells harboring a deletion of the
FAA1 gene including fatty acid transport [3], maintenance of intracellular acyl-CoA pools
[3], and fatty acid dependent regulation of transcription mediated by Spe23p and Mga2p [3].
Localization studies and proteomic approaches have shown this enzyme is both cytosolic and
membrane-associated (including on the plasma membrane [13], lipid particle [14],
mitochondria [15], and ER [16]) suggesting it may move to the membrane to facilitate catalysis,
particularly in the context of vectorial acylation. This membrane association is consistent with
studies by Bar-Tana et al. [17], who showed acyl-CoA synthetase activity in the rat is maximal
when the fatty acid substrate is presented in the presence of either nonionic detergent or
phospholipid vesicle. The preferred substrates for Faa1p are cis-monounsaturated long chain
fatty acids; this enzyme also activates trans-monounsaturated, tetradecenoic fatty acids but
with more selectivity [18].
Long chain acyl-CoA synthetases are proposed to catalyze the formation of fatty acyl-CoA by
a two-step process proceeding through the hydrolysis of ATP to yield pyrophosphate. A central
feature of the catalysis is the formation of an enzyme-bound adenylated intermediate [19]. This
activation step initially involves an acyl-phosphate bond formation between the carboxyl group
of the fatty acid and the α-phosphate of ATP. Subsequently a transfer of the fatty acyl group
to the sulfhydryl group of coenzyme A occurs thereby releasing AMP.
fatty acid+ATP => fatty acyl-AMP + PPi
fatty acyl-AMP+CoA => fatty acyl-CoA + AMP
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In the present work, we have purified the ACSL Faa1p to homogeneity as part of our efforts
to define the biochemical mechanisms operational in the vectorial transport and activation of
exogenous long chain fatty acids. Following over expression, Faa1p was purified in the
presence of 0.1% η-dodecyl-β-maltoside and 1mM ATP. This is the first work, which describes
the purification and comprehensive characterization of a eukaryotic ACSL. Previous studies
have defined the kinetic mechanism of a partially purified acyl-CoA synthetase from rat
microsomes and inferred the kinetic mechanism from the structure of the acyl-CoA synthetase
of Thermus thermophilus (likely has specificity for medium chain fatty acids) [17,20,21]. In
the first study, total acyl-CoA synthetase activity was purified from rat microsomes and
characterized kinetically; this is likely the contribution of several different ACSL isoforms as
opposed to a highly purified single enzyme ([17]; see also [22]). In the second study the kinetic
mechanism was inferred based on the structure of the bacterial enzyme in lieu of mechanistic
studies [21]. The present work demonstrates the highly purified ACSL Faa1p behaves as a
dimer as measured on an analytical gel filtration column and has an obligate requirement for
ATP and Mg+2 or Mn+2 for activity. Further, initial velocity studies completed on highly
purified Faa1p demonstrate the enzyme reaction is Bi Uni Uni Bi Ping Pong, consistent with
other adenylate-forming enzymes.
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MATERIALS AND METHODS
Construction of FAA1 Expression System and Over Expression of Faa1p in Escherichia coli
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The FAA1 gene was amplified by PCR from plasmid pBB319 (gift from Dr. Jeffrey Gordon,
Washington University, St. Louis MO) using a pair of oligonucleotide primers (50µM; forward
– 5’-CGACGGTCCATATGGTTGCTCAATATACCGT-3’; reverse - 5’CATAGTTGGAGCTCTCAGTGATGGTGATGGTG-3’) designed to contain NdeI and ScaI
sites at the 5’- and 3’-ends respectively. PCR products were purified using a QIAQuick spin
column (Qiagen, Inc., Valencia CA), digested with the restriction enzymes NdeI and SacI and
subsequently ligated into the T7-RNA responsive expression plasmid pET21-a (Novagen,
Madison, WI) to yield pDB222. The DNA sequence of FAA1 in pDB222 was verified by dyeterminator sequencing. For expression of Faa1p-6×His, the plasmid pDB222 was transformed
into E. coli strain LS2226 (BL21-CodonPlus (DE3) ΔfadD∷KnR). Transformants were grown
in 2×YT (1.6% tryptone, 1% yeast extract, 0.5% NaCl) supplemented with ampicillin (100µg/
ml) and kanamycin (45µg/ml) in a gyratory incubator/shaker at 22°C until they reached an
absorbance of A600 0.6–0.8 (3–4hr). Isopropyl-β-D-thiogalactopyranoside (IPTG; 1mM, final
concentration) was added to induce Faa1p-6×His and incubation continued at 15°C for 16hr.
Cells were harvested by centrifugation (4,000 ×g, 15min), washed with 1X PBS and frozen at
−80°C until use.
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Purification of Faa1p
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Faa1p-6×His was purified from soluble crude extract by chromatographic methods. E. coli
cells (1L) were suspended in 100ml of extraction buffer (50mM Hepes/NaOH, pH 7.4, 0.5M
NaCl, 15% glycerol, 0.1% η-dodecyl-β-maltoside (DDM), 1mM PMSF, 1mM ATP, 5mM
MgCl2) and were lysed by sonication in an ice water bath (5min; 30s on/off intervals). The cell
lysate was spun at 27,000 ×g for 25min at 4°C to yield a soluble cell-free extract. All subsequent
purification processes were accomplished at 4°C. The soluble cell extract was applied to a
gravity column (1.5 × 10 cm; Bio-Rad, Hercules, CA) packed with 5ml Ni-NTA resin (Qiagen,
Inc., Valencia CA) and pre-equilibrated with buffer A (50mM Hepes/NaOH, pH 7.4, 0.5M
NaCl, 10% glycerol, 0.05% η-dodecyl-β-maltoside (DDM), 1mM ATP, 5mM MgCl2). The
column was washed sequentially with 120ml of buffer A and 50ml of buffer A containing
20mM imidazole to elute unbound protein. Bound Faa1p was eluted with 25ml buffer A
containing 250mM imidazole. Fractions containing active Faa1p were pooled (4–5 ml) and
applied to a Sephacryl S-200 HR size exclusion column (1.6 × 60cm; GE Healthcare,
Piscataway, NJ) pre-equilibrated with buffer A attached to an FPLC system (Biologic HR
workstation, Bio-Rad). The Sephacryl S-200 HR column was run at a flow rate of 0.5ml/min
and 1ml fractions were collected. Fractions containing Faa1p activity were pooled,
concentrated to 6–8mg/ml and subsequently used for biochemical analysis.
Purity of the different protein samples was evaluated by SDS polyacrylamide gel
electrophoresis. Apparent molecular weight (Mr) was determined by comparison to
BenchMark™ pre-stained protein ladder (Invitrogen, Carlsbad, CA). Protein concentrations
were measured using the Bradford total protein assay with bovine serum albumin as the
standard.
The sequence and monomeric molecular weight of purified Faa1p was determined using ion
trap-nanoelectrospray mass spectrometry performed on a ThermoFinnigan LTQ MS at the
Biological Mass Spectrometry and Proteomics Facility (Wadsworth Center, Albany NY).
Protein identification and molecular weight was determined by querying the DNA/protein
databases with MS/MS spectra using the Turbo SEQUEST.
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Analytical Size Exclusion Chromatography
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Size exclusion chromatography was performed at 4°C on a Superose™ 6 10/300 GL column
(1.0 × 30cm; GE Healthcare). The column was equilibrated with buffer A and run with a flow
rate of 0.4ml/min. Protein standards (Bio-Rad) were used to calibrate the sizing column and
included bovine thyroglobulin (670,000), bovine gamma globulin (158,000), chicken
ovalbumin (44,000), horse myoglobin (17,000) and vitamin B-12 (1,350). Faa1p was detected
by absorbance at 280nm and by measuring acyl-CoA synthetase activity.
Determination of Acyl-CoA Synthetase Activity
Acyl-CoA synthetase activity was measured using standard conditions as previously described
[23]. The standard reaction mixtures contained 50mM Tris/HCl, pH 8.0, 10mM ATP, 10mM
MgCl2, 0.3mM dithiothreitol (DTT), 0.01% Triton X-100, 50µM [³H] oleate (or other fatty
acids substrates) and 200µM coenzyme A (CoA). Fatty acid stocks (free acid) were prepared
in 10mg/ml α-cyclodextrin. The reaction was initiated by the addition of CoA at 30°C,
continued for 15min and terminated by the addition of 2.5ml of isopropanol/η-heptane/1M
H2SO4 (40:10:1). The free fatty acid was removed by sequential organic extractions using ηheptane. Acyl-CoA formed during the reaction remained in the aqueous fraction and was
quantified by scintillation counting. Data were analyzed by analysis of variance using PRISM
software (GraphPad Software Inc., San Diego, CA).
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To test the heat stability, purified Faa1p was incubated for 30min at temperatures ranging from
4°C to 50°C prior to assay of acyl-CoA synthetase activity as detailed above. The effect of pH
on enzyme activity was evaluated using a three-component buffer system containing 75mM
bis-Tris, 38mM Hepes and 38mM CHES; the pH was adjusted to 5.5–9.5 using either NaOH
or HCl. The requirement for divalent metal cations was evaluated using MgCl2, MnCl2 and
CoCl2. Nucleotide (ATP, AMP) or nucleotide analogs (adenosine 5'-methylenetriphosphate
(AMP-CPP) and adenylyl methylenediphosphate (AMP-PCP)) were used to assess ATP
requirement and provide insights into the nature of the nucleotide-binding site within the
enzyme.
Kinetic Studies and Determination of Enzyme Reaction Mechanism
The kinetic properties of purified Faa1p were determined by monitoring oleoyl-CoA synthetase
activity; initial reaction rates were measured under standard assay conditions at various
concentrations of ATP (0–1mM) or CoA (0–200µM) or oleate (0–100µM) as detailed in the
figures and figure legends. The curves from the Michaelis-Menten equation were fit through
the initial rate data by nonlinear regression using the PRISM software (GraphPad Software
Inc.).
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Initial velocities were measured by choosing enzyme concentrations ensuring a linear response
during measurement. For these studies, Faa1p was purified in the absence of ATP. All
experiments were carried out for the overall reaction in which the concentrations of one
substrate was varied in the presence of different levels of a second substrate, while the
concentration of the third substrate was held constant [24,25]. Kinetic results were analyzed
using double-reciprocal plots followed by replots of slopes and intercepts as a function of the
reciprocal concentration of the changing fixed substrate in the initial-velocity studies or the
inhibitor concentration in the product-inhibition studies [26]. The concentrations of the product
inhibitors is noted within the text and figures in Results. The data reported were representative
sets of experiments carried out at least three times.
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Materials
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Enzymes required for DNA manipulations were from New England Biolabs, Promega, or
Roche Molecular Biochemicals. [³H] labeled fatty acids were obtained from Perkin-Elmer.
Antibiotics and other supplements for bacterial growth were obtained from Difco and Sigma.
All other chemicals were obtained from standard suppliers and were of reagent grade.

RESULTS
Purification and characterization of the ACSL Faa1p
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Faa1p was purified from E. coli as a hexameric histidine tagged protein following expression
as detailed in Experimental Procedures. Following the Sephacryl S-200 HR size exclusion
column, the final protein samples were concentrated to 6–8mg/ml in 50mM Hepes, pH7.4;
1mM ATP, 5mM MgCl2, 0.5M NaCl, 10% glycerol, 0.05% DDM (Figure 1A). In a typical
purification experiment, there was routinely a 200-fold enrichment of acyl-CoA synthetase
activity with a yield of 8–10mg pure Faa1p. Given the activity of the enzyme in both the crude
extract and in a highly purified form, we conclude that heterologous expression in E. coli at
15°C results in a properly folded protein. The sequence of the highly purified Faa1p was
confirmed using ion trap-nanoelectrospray mass spectrometry, which also defined a molecular
weight of 77,817. The protein is stable and retains activity and homogeneity for up to 7 days
at 4°C; the protein also retains activity for at least 4 months when flash-frozen in liquid nitrogen
in aliquots and stored at −80°C. When ATP was eliminated from the buffers used in
purification, peptide fragments were noted after 48hr of storage at 4°C or when flash frozen,
which was also accompanied by a loss of activity. For the mechanistic studies detailed below,
Faa1p purified in the absence of ATP was used immediately. Protein purified using these
methods were used in all of the kinetic experiments.
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Like other ACSLs, Faa1p appears to be a homodimer based on its elution patterns from an
analytical size exclusion column in the presence of 0.05% DDM (Figure 1B). Purified Faa1p
elutes from the Superose 6 10/300 column at 17min, which is consistent with a native MW of
~145,000, with the caution that this column was run using a buffer system containing 0.05%
DDM. As noted above, the inclusion of 0.05% DDM maintained both the stability and activity
of Faa1p. Considerable effort was expended to define these conditions, including studies
evaluating enzyme activity and stability in the presence of several other nonionic detergents
including η-octyl-β-D-glucopyranoside (OG), lauryldimethylamine-oxide (LDAO), dodecyl
nonaoxyethylene ether (C12E9), and tetraethylene glycol monooctyl ether (C8E4). We found
for example when 1% or 0.5% OG was used, Faa1p eluted from the analytical sizing column
as a monomer; 0.2% LDAO on the other hand maintained the protein primarily as a dimer. In
both cases purified Faa1p lost 50–60% original activity within 24hr, which was accompanied
by the appearance of peptide fragments (data not shown). Under conditions where the
concentrations of OG or LDAO were reduced to 0.05%, Faa1p eluted as high molecular weight
soluble aggregates that also lost activity (<50% original activity) when stored at 4°C for 24hr.
We also evaluated the detergents C12E9 and C8E4 (0.2% final concentrations) and found that
Faa1p eluted as a dimer but had 20–30% original enzymatic activity when maintained at 4°C
for 24hr. The optimal conditions for purification also included the addition of ATP (1mM, final
concentration), which we suspect enhances the stability of the ACSL Faa1p.
Enzymatic properties of the ACSL Faa1p
The kinetic parameters of Faa1p were initially evaluated using both oleate and ATP as variable
substrates. For these studies, ATP was not included in the purification buffers; given the
stability issues noted above, these experiments were completed immediately following
purification of Faa1p. Using standard assay conditions, we evaluated total oleoyl-CoA
synthetase activity as a function of enzyme concentration (Figure 2A). The reaction was linear
Biochim Biophys Acta. Author manuscript; available in PMC 2008 September 1.
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from 1–3µg of purified Faa1p; above 3µg purified Faa1p, the reaction was not linear, which
may be in part due to is association with the membrane. For all of the kinetic studies detailed
below, 1.5µg Faa1p was used. The oleoyl-CoA synthetase activities of Faa1p using varying
concentrations of oleate (holding ATP and CoA concentrations at 10mM and 200µM
respectively) in the reaction cocktail demonstrated this enzyme has typical Michaelis-Menten
profiles, which when displayed as a double-reciprocal plot gave a calculated Vmax and a Km
of 158.2 nmol/min/mg protein and 55.1µM respectively (Figure 2B). When ATP was used as
the variable substrate, similar Michaelis-Menten profiles were obtained giving a calculated
Vmax of 185.1 nmol/min/mg protein and a Km for ATP of 55.0µM. The enzyme required
Mg+2 for activity although Mn+2 provides equivalent function. (Table I). When Co+2 was use
as the divalent cation, the enzyme activity was reduced to less than 40% the levels defined
using Mg+2; the addition of Co+2 also had an apparent inhibitory effect as activity was reduced
when added to the reaction mixture along with Mg+2.
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The oleoyl-CoA synthetase activity of purified Faa1p was essentially unchanged over a range
of pH (7.0 – 8.5) but was markedly reduced at a pH below 6.5 (Figure 3A). This is consistent
with the notion that the fatty acid must be in an anionic state for maximal catalysis. Purified
Faa1p (in the presence of ATP) was incubated at the temperatures noted in Figure 3B for 30min,
warmed or cooled to room temperature and activity measured. These data showed that Faa1p
was able to tolerate changes in temperature from 4°C to 40°C; the enzyme lost essentially all
of its activity when heated to 50°C and above.
The two non-hydrolyzable ATP analogues AMPCPP and AMPPCP were able to bind to
purified Faa1p and essentially block all acyl-CoA synthetase activity. In these experiments,
the oleoyl-CoA synthetase activity of purified Faa1p was monitored under standard conditions
in the presence of 5mM AMPCPP or AMPPCP (100-fold excess when compared to ATP,
which was held at 50µM). At these concentrations of analogue, activity was depressed over
90% indicting both compounds compete for ATP binding thus blocking catalysis (data not
shown). These results, along with the kinetic studies using ATP as the variable substrate are
consistent with the conclusion the long chain acyl-CoA synthetase Faa1p has an absolute
requirement for ATP.
Mechanistic studies of the ACSL Faa1p
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Acyl-CoA synthetase requires three substrates: fatty acid, ATP and CoA; the mechanistic
studies detailed below used Faa1p, which was purified in the absence of ATP. Initial velocity
experiments of the forward reaction were conducted by keeping the concentration of one
substrate constant and varying the concentration of the remaining two (Figure 4). In the first
set of experiments the concentration of CoA was held constant at 200µM and the concentrations
of ATP and oleate varied (Figure 4A). The double-reciprocal pots of these data show a pattern
that is suggestive of mixed inhibition indicating the ATP and oleate binding sites are distinct,
which are likely to overlap during the formation of the acyl-adenylate intermediate. When ATP
was held at saturating concentrations (10mM) and the concentrations of oleate and CoA varied,
patterns of uncompetitive inhibition were observed (Figure 4B). These data argue the oleate
and CoA binding sites within Faa1p are distinct. Moreover these data are consistent with the
notion that ATP and oleate bind to the enzyme, which then catalyzes the formation of the acyladenylate, followed by the binding of CoA. When the concentration of oleate was held constant
and ATP and CoA concentrations varied, the same pattern of uncompetitive inhibition was
observed (Figure 4C). These data also support the ordered binding of substrates (oleate and
ATP followed by CoA) in the catalytic cycle of the ACSL Faa1p. These data are consistent
with the initial velocity rate law for a Bi Uni Uni Bi Ping Pong mechanism [26].
Product inhibition studies were completed to discern the order in which products were released
from the enzyme (Figure 5). When evaluated in combination with varying concentrations of
Biochim Biophys Acta. Author manuscript; available in PMC 2008 September 1.

Li et al.

Page 7

NIH-PA Author Manuscript

ATP, AMP functioned as a competitive inhibitor of the enzyme (Figure 5A). The patterns of
inhibition by pyrophosphate in combination with varying concentrations of oleate were mixed,
but the kinetic behavior was more competitive in nature (Figure 5B). When varying
concentrations of AMP and CoA were used in the product inhibition studies, the pattern was
non-competitive (Figure 5C). Collectively these data are consistent with the release of PPi from
a site on the enzyme, which overlaps the site occupied by the acyl-adenylate. CoA appears to
bind in a site distinct from AMP and thus its binding site is likely to be distinct from that of
the acyl-adenylate. From these studies, in the absence of either AMP or PPi as a product
inhibitor, the Vmax calculated for the enzyme ranged between 13.5nmol/min/mg protein to 27.3
nmol/min/mg protein (Table II). The Ki of AMP was in the low mM range (5.2 mM); due to
the mixed nature of inhibition by PPi, both Ki and Ki’ were defined (2.1mM and 1.4mM
respectively). In the initial velocity experiments varying PPi and oleate, the Km of oleate was
83µM; this value is consistent with the Km for oleate calculated from the Lineweaver-Burke
plot in Figure 2.
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The initial velocity and product inhibition studies are consistent with a Bi Uni Uni Bi Ping
Pong mechanism. The initial velocity experiments using varying concentrations of oleate and
ATP and the results from the product inhibition studies using varying concentrations of PPi
and oleate were indicative of competitive inhibition, but still rather mixed. In the case of the
forward reaction experiments using oleate and ATP as the variable substrates, we suspect this
mixed pattern of inhibition is due to overlap between the fatty acid and ATP binding sites
overlapping following ligand binding to facilitate the formation of the acyl-adenylate. In the
case of the product inhibition studies, the same type of mixed inhibition was seen when using
PPi and oleate as the variable substrates. Here again there is some indication the sites are
distinct, but the pattern is more similar to competitive inhibition, which we suggest is the result
of independent sites that become overlapped during catalysis.

DISCUSSION
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These studies provide the first comprehensive kinetic evaluation of the highly purified ACSL
Faa1p from S. cerevisiae. This enzyme catalyses the formation of acyl-CoA by a two step
process that proceeds through the formation of an acyl-adenylate intermediate; initial velocity
studies are consistent with a Bi Uni Uni Bi Ping Pong mechanism. The sequence and
monomeric molecular weight of 77,817 of purified Faa1p was confirmed using ion trapnanoelectrospray mass spectrometry. Maximal activity of the enzyme was retained when
purified in the presence of 0.05% η-dodecyl-β-maltoside (DDM). Moreover, the enzyme
retained stability when purified in the presence of ATP and Mg+2. In the presence of 0.05%
DDM, the enzyme is a homodimer as analyzed using both an analytical sizing column and
analytical ultracentrifugation. The linear range of enzyme activity was from 0.5–3µg purified
Faa1p. The loss of linearity above 3µg of enzyme may be the consequence of the requirement
of this enzyme to associate with the membrane during catalysis. The enzyme has a high affinity
for long chain fatty acids and is active over a range of pH consistent with the fatty acid anion
as the preferred substrate. Previous work has shown Faa1p has a preference for fatty acid
substrates ranging from C10-C18. The preferred substrates for Faa1p are cis-monounsaturated
long chain fatty acids; this enzyme also activates trans-monounsaturated, tetradecenoic acids,
but with more selectivity. For Faa1p, the activity toward E4 and E6 compounds were
comparable to the cis isomers, while E2 and E5were not activated [7]. While Faa1p is
insensitive to triacsin C, the AMP-palmitate analogue adenosine 5’-hexadecylphosphate
(AMPC16) inhibits activity [27]. AMPC16 mimics the adenylated intermediate formed in the
enzyme reaction and in addition results in the accumulation of free fatty acids and disruption
of membrane integrity [28]. In the present work we showed oleoyl-CoA synthetase activity is
essentially eliminated in the presence of the nucleotide analogues AMPCPP and AMPPCP.
These studies collectively support the conclusion that Faa1p requires ATP for catalysis and
Biochim Biophys Acta. Author manuscript; available in PMC 2008 September 1.
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that this reaction proceeds through the formation of the acyl-adenylate. Using a rat microsomal
preparation of acyl-CoA synthetase Bar-Tana et al. [20] concluded the reaction was Bi Uni
Uni Bi Ping Pong, a mechanism that is generally accepted for both acetyl and acyl-CoA
synthetases. In the context of ACSLs, the present work used a highly purified preparation of
Faa1p, which was extensively characterized and verified the enzyme reaction mechanism.
While the work is fundamentally descriptive in nature, this work is essential to direct studies
in understanding how these enzymes function in the vectorial transport and activation of
exogenous fatty acids.
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The purification of Faa1p posed a considerable challenge as this enzyme could not be purified
and maintained in a homogeneous state in the absence of a nonionic detergent. Our early
attempts to purify Faa1p in the absence of detergent resulted in the formation of higher order
aggregates, which based on analytical ultracentrifugation were generally 8-mers, 16-mers and
32-mers as opposed to dimers. This type of behavior is reminiscent of membrane-bound and–
associated proteins. Like several other ACSLs that have been described, Faa1p is likely to be
membrane associated. Total acyl-CoA synthetase activity from rat microsomes is maximal
when assayed in the presence of nonionic detergent or phospholipid [29]. The E. coli ACSL
FadD also prefers a hydrophobic environment for maximal activity [30]. We have previously
demonstrated Faa1p functions in the vectorial acylation of exogenous long chain fatty acids
[3,13]. Of particular note was the finding that Faa1p and the fatty acid transport protein Fat1p
form a functional complex at the plasma membrane. We suggest dimeric Faa1p functions at
the membrane surface to abstract fatty acids as part of its catalytic cycle.
This work has defined the kinetic parameters of the highly purified ACSL Faa1p, which are
essential to understand the catalytic patterns of this enzyme and moreover how it functions in
the activation and trafficking of long chain fatty acids. Current studies stemming from our
ability to purify Faa1p and maintain the enzyme in a monodispersed state are directed towards
defining the structure of this long chain acyl-CoA synthetase.
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Figure 1. Purification of the long chain acyl-CoA synthetase Faa1p following expression in E. coli

A. SDSPAGE of protein during the different steps of purification (S200-1 and S200-2
represents combined and concentrated fractions from the Faa1p peak from the S200 column);
MW – molecular weight standards (indicated on the left). B. Determination of the native
molecular weight of purified Faa1p in 50mM Hepes, pH7.4; 1mM ATP, 5mM MgCl2, 0.5M
NaCl, 10% glycerol, 0.05% DDM using an analytical size exclusion column (Superose™ 6
10/300 GL). The insert shows the elution position of Faa1p at ~17ml (arrow) relative to the
standards used to calibrate the column (bovine thyroglobulin (670,000), bovine gamma
globulin (158,000), chicken ovalbumin (44,000), horse myoglobin (17,000) and vitamin B-12
(1,350).
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Figure 2. Characteristics of purified Faa1p

A. Acyl-CoA synthetase activity as a function of enzyme concentration; insert illustrates the
linearity of the reaction between 0.5 and 3µg of enzyme. B. Lineweaver-Burke plot of the
enzyme reaction as a function of varying oleate (C18:1) concentration (5–200µM) using 1.5µg
of purified enzyme. ATP and CoA concentrations were held constant at 10mM and 200µM
respectively. Vo−1 values are (nmol/min/mg protein)−1.
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Figure 3. Activity and stability of purified Faa1p

A. Enzyme activity was measured over a range of pH values using 1.5µg purified Faa1p; the
activity at pH of 8.0 was set to 100% (163.7±12.9 nmol/min/mg protein). B. The thermal
stability of Faa1p (1.5µg) was determined following incubation at the noted temperatures for
30min at which time activity was measured; the activity of Faa1p when maintained at 30°C
was set to 100% (157.5±17.3 nmol/min/mg protein). The error bars are the standard error of
the mean (n=3).
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Figure 4. Initial velocity studies of the acyl-CoA synthetase reaction using 1.5µg purified Faa1p

Double reciprocal plots where A. CoA concentrations were held constant at 200µM and ATP
(µM−1) and oleate (µM) concentrations varied as indicated; B. ATP concentrations were held
constant at 10mM and CoA (µM−1) and oleate (µM) concentrations varied as indicated; and
C. Oleate concentrations were held constant at 200µM and CoA (µM−1) and ATP (µM)
concentrations varied as indicated. Vo−1 values are (nmol/min/mg protein)−1. Shown are
representative experiments of an n=4.
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Figure 5. Initial velocity studies of the acyl-CoA synthetase reaction in the presence of end products
using 1.5µg purified Faa1p

Double reciprocal plots where A. CoA and oleate concentrations were held constant at 20µM
and 50µM respectively and the concentrations of ATP (µM−1) and AMP (mM) varied as
indicated; B. CoA and ATP concentrations were held constant at 20µM and 5µM respectively
and the concentrations of oleate (µM−1) and pyrophosphate (PPi) (mM) varied as indicated;
and C. ATP and oleate concentrations were held constant at 100µM and 50µM respectively
and the concentrations of CoA (µM−1) and AMP (mM) varied as indicated. Vo−1 values are
(nmol/min/mg protein)−1. Shown are representative experiments of an n=4.
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Table I

Cation requirement for long chain acyl-CoA synthetase activity
Added Cation
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10mM MgCl2 (normal assay)
10mM MnCl2
10mM CoCl2
5mM MgCl2 + 5mM MnCl2
5mM MgCl2 + 5 mM CoCl2

Specific Activity (±SE)1
(nmol/min/mg protein)

%2

145.5 (12.5)
121.9 (9.1)
56.3 (3.8)
141.2 (6.8)
62.1 (9.0)

100
84
39
97
42

1

SE – standard error of the mean, n=4

2

Compared to the activity under normal assay conditions (50mM Tris/HCl, pH 8.0, 10mM ATP, 10mM MgCl2, 0.3mM DTT, 0.01% Triton X-100, 50µM

[³H] oleate and 200µM CoA).
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Table II

Kinetic parameters of Faa1p from initial velocity experiments
Forward reaction
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Varying CoA and ATP concentrations; concentration of oleate (50µM) held constant
Km
18.3µM CoA
Km
51.6µM ATP
Vmax
22.5nmol/min/mg
Product inhibition
Varying PPi and oleate concentrations; ATP (5µM) and CoA (20µM) concentrations held constant
Km
83.0µM oleate
Vmax
13.5nmol/min/mg (in the absence of PPi)
Ki
2.1mM PPi
Ki’
1.4mM PPi
Varying AMP and CoA concentrations; ATP (100µM) and oleate (50µM) concentrations held constant
Km
34.4µM CoA
Vmax
27.3nmol/min/mg (in the absence of AMP)
Ki
5.2mM AMP
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